Airmen from Little Rock Air Force Base, Arkansas, tested the capabilities of the M69 Joint Service Aircrew Mask Strategic Aircraft for implementation and field use for individual respiratory, ocular and percutaneous protection against chemical biological agents on the C-130J airframe April 25 – 30. The M69 is intended to replace the Aircrew Eye and Respiratory Protection system.
A joint team led by Air Combat Command’s 52nd Wing and 28th Test and Evaluation Squadron located at Eglin Air Force Base, Florida, provided guidance and supervision to Airmen as they tested the new Aircrew Chemical Biological Radiological Nuclear system on C-130J aircraft.